Day One Biopharmaceuticals Inc (DAWN)
13.72
+0.38
(+2.85%)
USD |
NASDAQ |
Nov 22, 16:00
15.14
+1.42
(+10.35%)
After-Hours: 20:00
Day One Biopharmaceuticals Enterprise Value: 825.23M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 825.23M |
| November 21, 2024 | 786.91M |
| November 20, 2024 | 815.14M |
| November 19, 2024 | 805.06M |
| November 18, 2024 | 753.63M |
| November 15, 2024 | 783.88M |
| November 14, 2024 | 885.74M |
| November 13, 2024 | 939.18M |
| November 12, 2024 | 1.019B |
| November 11, 2024 | 1.041B |
| November 08, 2024 | 1.094B |
| November 07, 2024 | 1.031B |
| November 06, 2024 | 997.68M |
| November 05, 2024 | 969.44M |
| November 04, 2024 | 935.15M |
| November 01, 2024 | 919.02M |
| October 31, 2024 | 926.07M |
| October 30, 2024 | 900.86M |
| October 29, 2024 | 888.76M |
| October 28, 2024 | 900.86M |
| October 25, 2024 | 913.97M |
| October 24, 2024 | 900.86M |
| October 23, 2024 | 886.23M |
| October 22, 2024 | 899.34M |
| October 21, 2024 | 946.72M |
| Date | Value |
|---|---|
| October 18, 2024 | 954.78M |
| October 17, 2024 | 961.84M |
| October 16, 2024 | 954.78M |
| October 15, 2024 | 936.64M |
| October 14, 2024 | 883.21M |
| October 11, 2024 | 840.87M |
| October 10, 2024 | 805.58M |
| October 09, 2024 | 858.00M |
| October 08, 2024 | 821.71M |
| October 07, 2024 | 810.62M |
| October 04, 2024 | 863.04M |
| October 03, 2024 | 832.80M |
| October 02, 2024 | 814.65M |
| October 01, 2024 | 852.96M |
| September 30, 2024 | 845.91M |
| September 27, 2024 | 1.030B |
| September 26, 2024 | 1.043B |
| September 25, 2024 | 1.020B |
| September 24, 2024 | 1.048B |
| September 23, 2024 | 1.040B |
| September 20, 2024 | 1.091B |
| September 19, 2024 | 1.046B |
| September 18, 2024 | 993.86M |
| September 17, 2024 | 990.91M |
| September 16, 2024 | 978.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
91.41M
Minimum
May 27 2022
1.557B
Maximum
Aug 12 2022
885.49M
Average
922.29M
Median
Jul 27 2022
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -31.63M |
| Electromed Inc | 238.10M |
| Xtant Medical Holdings Inc | 83.10M |
| Myomo Inc | 147.33M |
| Catheter Precision Inc | 3.859M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 37.04M |
| Revenue (Quarterly) | 93.76M |
| Total Expenses (Quarterly) | 64.12M |
| EPS Diluted (Quarterly) | 0.38 |
| Gross Profit Margin (Quarterly) | 98.30% |
| Profit Margin (Quarterly) | 39.50% |
| Earnings Yield | -7.51% |